Predicted Trait | |
Reported Trait | Kidney cancer |
Mapped Trait(s) | renal carcinoma (EFO_0002890) |
Score Construction | |
PGS Name | PRS_Kidney |
Development Method | |
Name | Genome-wide significant variants |
Parameters | NR |
Variants | |
Original Genome Build | hg19 |
Number of Variants | 15 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000135 |
Citation (link to publication) | Jia G et al. JNCI Cancer Spectr (2020) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 142,756 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
Europe PMC: 22113997 |
[
|
European | ATBC, CEERCC, CPSII, PLCO, USKC |
GWAS Catalog: GCST001750 Europe PMC: 23184150 |
10,781 individuals | European | 8 cohorts
|
GWAS Catalog: GCST002273 Europe PMC: 24220699 |
69,230 individuals | European | ICR, deCODE |
GWAS Catalog: GCST000907 Europe PMC: 21131975 |
12,277 individuals | European | 14 cohorts
|
GWAS Catalog: GCST001283 Europe PMC: 22010048 |
2,410 individuals | European | MDACCS |
GWAS Catalog: GCST004710 Europe PMC: 28598434 |
31,190 individuals | European | 29 cohorts
|
GWAS Catalog: GCST002835 Europe PMC: 25826619 |
10,871 individuals | European | NCI, UKBS, WTCCC |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM001652 | PSS000856| European Ancestry| 400,812 individuals |
PGP000135 | Jia G et al. JNCI Cancer Spectr (2020) |
Reported Trait: Incident kidney cancer | — | AUROC: 0.567 [0.543, 0.591] | — | Genotyping array | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000856 | Data and diagnoses on site-specific incident cancers were provided by the National Health Service Information Centre for participants from England and Wales (follow-up through March 31, 2016) and by the NHS Central Register Scotland for participants from Scotland (follow-up through October 31, 2015). Cancers were coded by the International Classification of Diseases, Ninth Revision (ICD-9) or the International Classification of Diseases, Tenth Revision (ICD-10). Kidney Cancer=(ICD-9 = 189.0 or ICD-10 = C64) | Median = 5.8 years | [ ,
46.5 % Male samples |
— | European | — | UKB | — |